Your browser doesn't support javascript.
loading
Tralokinumab does not impact vaccine-induced immune responses: Results from a 30-week, randomized, placebo-controlled trial in adults with moderate-to-severe atopic dermatitis.
Merola, Joseph F; Bagel, Jerry; Almgren, Peter; Røpke, Mads A; Lophaven, Katja W; Vest, Natacha Strange; Grewal, Parbeer.
Affiliation
  • Merola JF; Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts. Electronic address: jfmerola@bwh.harvard.edu.
  • Bagel J; Eczema Treatment Center of New Jersey, East Windsor, New Jersey.
  • Almgren P; LEO Pharma A/S, Ballerup, Denmark.
  • Røpke MA; LEO Pharma A/S, Ballerup, Denmark.
  • Lophaven KW; LEO Pharma A/S, Ballerup, Denmark.
  • Vest NS; LEO Pharma A/S, Ballerup, Denmark.
  • Grewal P; Division of Dermatology, University of Alberta, Edmonton, Canada.
J Am Acad Dermatol ; 85(1): 71-78, 2021 Jul.
Article de En | MEDLINE | ID: mdl-33744356

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Vaccin diphtérie-tétanos-coqueluche / Vaccins antiméningococciques / Produits dermatologiques / Anticorps monoclonaux Type d'étude: Clinical_trials Limites: Adult / Female / Humans / Male / Middle aged Langue: En Journal: J Am Acad Dermatol Année: 2021 Type de document: Article Pays de publication: États-Unis d'Amérique

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Vaccin diphtérie-tétanos-coqueluche / Vaccins antiméningococciques / Produits dermatologiques / Anticorps monoclonaux Type d'étude: Clinical_trials Limites: Adult / Female / Humans / Male / Middle aged Langue: En Journal: J Am Acad Dermatol Année: 2021 Type de document: Article Pays de publication: États-Unis d'Amérique